Sections 14 and 14A Notice
On 30 September 2016, a delegate of the Secretary of the Department of Health, on the application of Sandoz Pty Ltd , consented under sections 14 and 14A of the Therapeutic Goods Act 1989 (the Act) to the importation and supply of the products outlined in Attachment 1; that do not conform with the requirements of the sub-clause 3(2)(l) of Therapeutic Goods Order No. 69 – General requirements for labels for medicines, in that the labels of the products do not contain the current company address.
The consent is effective from 30 June 2016 until 31 July 2017.
The consent is subject to the following conditions:
Attachment 1
Submission No. | Products |
PM-2016-02744-1-2 (Sponsor: Sandoz Pty Ltd) |
|
PM-2016-02759-1-1 (Sponsor: Sanofi- Aventis Australia Pty Ltd) |
|
PM-2016-02758-1-1 (Sponsor: Generic Health Pty Ltd) |
|
PM-2016-02760-1-3 (Sponsor: Servier Laboratories (Australia) Pty Ltd) |
|
PM-2016-02762-1-5 (Sponsor: Accord Healthcare Pty Ltd) |
|
PM-2016-02757-1-4 (Sponsor: Dr Reddy’s Laboratories Australia Pty Ltd) |
|
PM-2016-02761-1-1 (Sponsor: Southern Cross Pharma Pty Ltd) |
|